Publications by authors named "Carlo Albera"

Claim this Profile
C
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes.
Ilaria Ferrarotti, Davide Piloni, Asia Filosa, Stefania Ottaviani, Valentina Barzon, Carlo Albera

Pulmonology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of Effectiveness of Pirfenidone in Elderly Patients with Progressive Functional Impairment: A Real-World Retrospective Study in IPF.
Stefano Levra, Cecilia Rivero, Fabiana Giannoccaro, Giuseppe Guida, Francesca Bertolini, Carlo Albera

Biomedicines· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score.
Silvia Papa, Michele D'Alto, Laura Scelsi, Mauro Acquaro, Francesca Adamo, Carlo Albera

Vascul Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection.
Paolo Solidoro, Federico Sciarrone, Francesca Sidoti, Filippo Patrucco, Elisa Zanotto, Carlo Albera

Viruses· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between high-resolution computed tomography appearance and histopathological features in the diagnosis of interstitial lung diseases. A real-life study.
Paraskevas Lyberis, Giulia Verri, Paolo Solidoro, Federico Femia, Costanza Perotti, Carlo Albera

Minerva Surg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes Virus Infection in Lung Transplantation: Diagnosis, Treatment and Prevention Strategies.
Filippo Patrucco, Antonio Curtoni, Francesca Sidoti, Elisa Zanotto, Alessandro Bondi, Carlo Albera

Viruses· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measure of lung dielectric proprieties in patients with Idiopathic Pulmonary Fibrosis: correlation with clinical, radiological and pulmonary functional parameters.
Filippo Patrucco, Carlo Albera, Mattia Bellan, Martina Zava, Francesco Gavelli

Respir Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.
Jürgen Behr, Steven D Nathan, Ulrich Costabel, Carlo Albera, Wim A Wuyts

Adv Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keep on tailoring CMV management in lung transplantation: 24 versus 12-month CMV hyperimmune globulins regimen effects in combined universal prophylaxis.
Paolo Solidoro, Filippo Patrucco, Carlo Albera, Valentina Pennazio, Francesco Guerrera

Panminerva Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience.
Stefano Levra, Giuseppe Guida, Andrea Elio Sprio, Flavio Crosa, Paolo Carlo Ghio, Carlo Albera

Biomedicines· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosis.
Cristiano Miotti, Andrea M D'Armini, Beatrice Scardovi, Stefano Ghio, Gianfranco Sinagra, Carlo Albera

Minerva Cardiol Angiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: An Italian cohort study.
Carlotta Sacerdote, Lorenzo Milani, Anna Castiglione, Eva Pagano, Enrica Migliore, Carlo Albera

J Infect· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy.
Stefania Nicola, Richard Borrelli, Irene Ridolfi, Virginia Bernardi, Paolo Borrelli, Carlo Albera

J Pers Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib in IPF: Post hoc Analysis of the Italian FIBRONET Observational Study.
Sergio Harari, Alberto Pesci, Carlo Albera, Venerino Poletti, Christian Amici

Respiration· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Simple, Rapid, and Cost-Effective Method for Acute Rejection Monitoring in Lung Transplant Recipients.
Monica Sorbini, Gabriele Togliatto, Fiorenza Mioli, Erika Simonato, Matteo Marro, Carlo Albera

Transpl Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
Paolo Solidoro, Carlo Albera, Fulvia Ribolla, Michela Bellocchia, Luisa Brussino

Front Med (Lausanne)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives.
Luca Mesin, Stefano Albani, Piero Policastro, Paolo Pasquero, Massimo Porta, Carlo Albera

Front Cardiovasc Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center.
Paolo Solidoro, Stefania Nicola, Irene Ridolfi, Giorgio Walter Canonica, Francesco Blasi, Carlo Albera

Biomedicines· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice.
Paolo Solidoro, Filippo Patrucco, Massimo Boffini, Mauro Rinaldi, Chiara Airoldi, Carlo Albera

Ther Adv Respir Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective.
Carlo Albera, Giulia Verri, Federico Sciarrone, Elena Sitia, Mauro Mangiapia

Biomedicines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awake or intubated surgery in diagnosis of interstitial lung diseases? A prospective study.
Francesco Guerrera, Lorena Costardi, Giulio L Rosboch, Paraskevas Lyberis, Edoardo Ceraolo, Carlo Albera

ERJ Open Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey.
Manuela Funke-Chambour, Carlo Albera, Elisabeth Bendstrup, Ulrich Costabel, Jan C Grutters

Eur Respir J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
Filippo Patrucco, Elias Allara, Massimo Boffini, Mauro Rinaldi, Cristina Costa, Carlo Albera

Ther Adv Chronic Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience.
Filippo Patrucco, Carlo Albera, Michela Bellocchia, Valentina Foci, Francesco Gavelli

Respiration· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.
Luca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, Carlo Albera, David J Lederer

Lancet Respir Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis